Dourish C T
Neuropharmacology. 1981 Nov;20(11):1067-72. doi: 10.1016/0028-3908(81)90098-8.
The behavioural consequences of daily beta-phenylethylamine (PEA) administration for a period of 6 weeks have been examined. Rats first showed signs of the 5-HT behavioural syndrome after a single injection of PEA (50mg/kg) or 7 daily injections of PEA (25mg/kg). The syndrome reached peak intensity after 3 weeks treatment and was prevented by pre-treatment with 5-HT antagonists mianserin and methysergide or the neuroloptic clozapine but relatively unaffected by pre-treatment with haloperidol. These data provide strong evidence for an effect of PEA on brain 5-HT mechanisms. Because of the similarity between PEA and amphetamine and the suggestion that PEA may be involved in the aetiology of schizophrenia, it is proposed that the mechanisms of action of PEA be reassessed taking into account its ability to affect 5-HT systems in addition to catecholaminergic systems.
已经对连续6周每日给予β-苯乙胺(PEA)的行为后果进行了研究。大鼠在单次注射PEA(50mg/kg)或连续7天注射PEA(25mg/kg)后首次出现5-羟色胺行为综合征的迹象。该综合征在治疗3周后达到强度峰值,并用5-羟色胺拮抗剂米安色林和甲基麦角新碱或神经安定药氯氮平预处理可预防,但用氟哌啶醇预处理相对无影响。这些数据为PEA对脑5-羟色胺机制的作用提供了有力证据。由于PEA与苯丙胺之间的相似性以及PEA可能参与精神分裂症病因学的提示,建议重新评估PEA的作用机制,考虑到它除了影响儿茶酚胺能系统外还具有影响5-羟色胺系统的能力。